Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-29 @ 1:21 PM
Study NCT ID:
NCT01233895
Status:
COMPLETED
Last Update Posted:
2010-11-03
First Post:
2010-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TED6420
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Trial Transparency Team
Old Organization:
sanofi-aventis